Liminatus Pharma, Inc Class A Common Stock

Quarterly Financials

Values in thousands 2025-03-31
Revenue
$0
Gross Profit
EBITDA
EBIT
Net Income
Net Change In Cash
0
Free Cash Flow
0
Cash
804
Basic Shares
27,064

Annual Financials

Values in thousands 2023-12-31 2022-12-31
Revenue
$0
$0
EBITDA
-4,809
-2,709
Net Income
-4,984
-2,928
Net Change In Cash
0
0
Free Cash Flow
-3,345
-869
Cash
434
5,048
Basic Shares
8,012
34,428

Earnings Calls

Quarter EPS
2025-06-30
$0.004
2025-03-31
$0
2024-12-31
-$0.12
2024-09-30
-$0.08